COMPANY

Cellipont Bioservices

Keywords: gene therapy CAR-T iPSC CDMO services

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Undisclosed round · amount not disclosed · announced Oct 7, 2024 Company release ↗
Source quote
- Oct 7, 2024 · Company release ↗
  “Head’s CEO role, Cellipont today announces a minority growth equity investment from HealthQuest Capital, a leading growth investor partnering with transformative healthcare companies.”

From the company’s own releases; this list is partial. All raises and deals

Feb 24, 2026 Partnership Partnership / licensing announced Feb 24, 2026. Source: company's own press page. source ↗
Oct 29, 2025 Partnership Partnership / licensing announced Oct 29, 2025. Source: company's own press page. source ↗
Jul 29, 2025 Partnership Partnership / licensing announced Jul 29, 2025. Source: company's own press page. source ↗
Jun 17, 2025 Partnership Partnership / licensing announced Jun 17, 2025. Source: company's own press page. source ↗
Dec 10, 2024 Partnership Partnership / licensing announced Dec 10, 2024. Source: company's own press page. source ↗
Oct 7, 2024 Raise Undisclosed round · amount not disclosed source ↗

Last 2 years.

Feb 24, 2026 Partnership / licensing announced Feb 24, 2026. Source: company's own press page. source ↗
Oct 29, 2025 Partnership / licensing announced Oct 29, 2025. Source: company's own press page. source ↗
Jul 29, 2025 Partnership / licensing announced Jul 29, 2025. Source: company's own press page. source ↗
Jun 17, 2025 Partnership / licensing announced Jun 17, 2025. Source: company's own press page. source ↗
Dec 10, 2024 Partnership / licensing announced Dec 10, 2024. Source: company's own press page. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗